Related Experiment Video
Updated: May 23, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Novel repressor regulates insulin sensitivity through interaction with Foxo1
Jun Nakae1, Yongheng Cao, Fumihiko Hakuno
1Frontier Medicine on Metabolic Syndrome, Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. jnakae35@sc.itc.keio.ac.jp
Abstract:
Forkhead box-containing protein o (Foxo) 1 is a key transcription factor in insulin and glucose metabolism. We identified a Foxo1-CoRepressor (FCoR) protein in mouse adipose tissue that inhibits Foxo1's activity by enhancing acetylation via impairment of the interaction between Foxo1 and the deacetylase Sirt1 and via direct acetylation. FCoR is phosphorylated at Threonine 93 by catalytic subunit of protein kinase A and is translocated into nucleus, making it possible to bind to Foxo1 in both cytosol and nucleus. Knockdown of FCoR in 3T3-F442A cells enhanced expression of Foxo target and inhibited adipocyte differentiation. Overexpression of FCoR in white adipose tissue decreased expression of Foxo-target genes and adipocyte size and increased insulin sensitivity in Lepr(db/db) mice and in mice fed a high-fat diet. In contrast, Fcor knockout mice were lean, glucose intolerant, and had decreased insulin sensitivity that was accompanied by increased expression levels of Foxo-target genes and enlarged adipocytes. Taken together, these data suggest that FCoR is a novel repressor that regulates insulin sensitivity and energy metabolism in adipose tissue by acting to fine-tune Foxo1 activity.
Insights
A novel protein, Foxo1-CoRepressor (FCoR), regulates insulin sensitivity and energy metabolism. FCoR fine-tunes Forkhead box-containing protein o (Foxo) 1 activity in adipose tissue, impacting glucose metabolism and adipocyte function.
Area of Science:
- Metabolic regulation
- Adipose tissue biology
- Molecular endocrinology
Background:
- Forkhead box-containing protein o (Foxo) 1 is a critical regulator of insulin and glucose metabolism.
- Understanding the precise mechanisms controlling Foxo1 activity is essential for metabolic health.
Purpose of the Study:
- To identify novel regulators of Foxo1 activity in adipose tissue.
- To elucidate the role of a newly identified Foxo1-CoRepressor (FCoR) in metabolic regulation.
Main Methods:
- Identification and characterization of FCoR in mouse adipose tissue.
- Investigating FCoR's interaction with Foxo1 and Sirt1.
- Phosphorylation site analysis of FCoR.
- Cellular studies using 3T3-F442A cells (knockdown and overexpression).
- In vivo studies using Lepr(db/db) mice, high-fat diet models, and Fcor knockout mice.
Main Results:
- FCoR inhibits Foxo1 activity by promoting its acetylation and disrupting its interaction with Sirt1.
- FCoR is phosphorylated by protein kinase A and translocates to the nucleus to bind Foxo1.
- FCoR knockdown in adipocytes enhances Foxo target gene expression and inhibits differentiation.
- FCoR overexpression in mice improves insulin sensitivity, reduces adipocyte size, and decreases Foxo target gene expression.
- Fcor knockout mice exhibit leanness, glucose intolerance, decreased insulin sensitivity, enlarged adipocytes, and increased Foxo target gene expression.
Conclusions:
- FCoR is a novel repressor of Foxo1 activity in adipose tissue.
- FCoR plays a significant role in regulating insulin sensitivity and energy metabolism.
- FCoR acts as a fine-tuner of Foxo1 activity, influencing adipocyte function and overall metabolic homeostasis.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Co-activators and Co-repressors
Co-activators and Co-repressors
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Operon Model

